Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies

NCT05957367 is registered in ClinicalTrials.gov with Deciphera Pharmaceuticals, LLC as lead sponsor.

NCT NCT05957367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Master Protocol for the Multi-Cohort, Phase 1/2 Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Lead sponsor
Deciphera Pharmaceuticals, LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 28, 2023
Completion date
March 31, 2029
Enrollment
94 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

gist